Impact of prior TNF inhibitor treatment on the time to achieve low disease activity and the duration of low disease activity in 17,858 European patients with axial spondyloarthritis initiating a TNF inhibitor or an IL-17A inhibitor
24/11/2025
Heberg J et al. (EuroSpA)
https://scientific.sparx-ip.net/archiveeular/?searchfor=eurospa&view=1&c=a&item=2025POS1154
EULAR 2025